港股市场今日震荡，创新药板块持续调整。其中，晶泰控股（02228.HK）股价表现疲软，盘中大跌8.92%，引发市场关注。
截至发稿，晶泰控股报价11.800港元/股。盘中交易数据显示，该股成交量达1.1824亿股，换手率为2.75%，振幅达7.64%。资金流向方面，该股今日资金流入5.06594亿港元，流出7.13581亿港元，呈现净流出态势。
值得注意的是，晶泰控股并非个案。港股创新药板块整体表现低迷，诺诚健华跌幅超过10%，歌礼制药跌幅接近8%，药明合联跌幅超过5%，药明生物跌幅接近5%。分析人士指出，近期市场风险偏好下降，加之创新药板块前期涨幅较大，投资者获利回吐意愿明显，导致板块整体承压。但长期来看，随着行业利好政策逐步落地及重要学术会议召开，创新药板块有望迎来估值修复机会。投资者仍需密切关注行业动态及个股基本面变化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.